The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management.

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management.
复制标题

DOI:
10.1093/europace/eun369
复制
发表时间:
2009-04
期刊:
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
影响因子:
--
通讯作者:
Steinbeck G
Steinbeck G
中科院分区:
其他
文献类型:
--
作者:
Nabauer M;Gerth A;Limbourg T;Schneider S;Oeff M;Kirchhof P;Goette A;Lewalter T;Ravens U;Meinertz T;Breithardt G;Steinbeck G

文献摘要

参考文献

被引文献

相似文献

本研究的目的是描述入组德国房颤能力网络(AFNET)中央登记处的房颤(AF)患者的特征,并评估德国不同医疗水平治疗患者的当前医疗实践。2004年2月至2006年3月,来自德国各级医疗保健的194家参与研究中心入组了9582例ECG记录的AF门诊和住院患者。2893例患者报告的房颤临床类型为阵发性,1873例为持续性,3134例患者为永久性,1035例患者为首次发作。诱发条件是常见的,并在87.6%的患者中存在。大多数患者有房颤症状(75.1%)。53.4%的有症状患者和47.8%的无症状患者接受了持续性AF的心律控制。适用指南认为符合条件的患者中有71.4%接受了预防卒中的抗凝治疗,指南不建议抗凝治疗的低风险患者中有48.4%接受了抗凝治疗。本登记研究深入了解了德国房颤患者的当前医疗护理。在合格患者中使用口服抗凝剂是报告的最高水平,而关于心率和节律控制的决定通常不遵循当前的建议。
The aim of this study was to describe the characteristics of patients with atrial fibrillation (AF) enrolled in the Central Registry of the German Competence NETwork on Atrial Fibrillation (AFNET) and to assess current medical practice in patients treated at various levels of medical care in Germany. From February 2004 to March 2006, 9582 ambulatory and hospitalized patients with ECG-documented AF were enrolled by 194 participating study centres from all levels of medical care in Germany. Clinical type of AF was reported as paroxysmal in 2893, persistent in 1873, and permanent in 3134 patients or classified as a first episode in 1035 patients. Predisposing conditions were common and present in 87.6% of the patients. Most patients were symptomatic with AF (75.1%). Rhythm control in persistent AF was provided to 53.4% of the symptomatic patients and to 47.8% of the patients without symptoms. Anticoagulation for stroke prevention was given to 71.4% of the patients considered eligible by applicable guidelines and to 48.4% of patients with low risk where guidelines do not recommend anticoagulation. This registry provides insight into current medical care of patients with AF in Germany. The use of oral anticoagulation in eligible patients was among the highest reported, whereas decisions on rate and rhythm control often do not follow current recommendations.
DOI: 10.1053/euhj.2000.2300
发表时间: 2001-10-01
影响因子: 39.3
作者:
Frykman, V;Beerman, B;Rosenqvist, M
通讯作者: Rosenqvist, M
DOI: 10.1016/s0140-6736(02)11315-8
发表时间: 2002-10-26
期刊: LANCET
影响因子: 168.9
作者:
Kirchhof, P;Eckardt, L;Borggrefe, M
通讯作者: Borggrefe, M
DOI: 10.1016/s0002-9149(98)00736-x
发表时间: 1998-10-16
影响因子: 2.8
作者:
Gallagher, MM;Camm, J
通讯作者: Camm, J
DOI: 10.1093/eurheartj/ehi306
发表时间: 2005-10-01
影响因子: 39.3
作者:
Testa, L;Biondi-Zoccai, GGL;Crea, F
通讯作者: Crea, F
DOI: 10.1016/j.jacc.2005.06.077
发表时间: 2005-11-01
影响因子: 24
作者:
Waldo, AL;Becker, RC;Colgan, KJ
通讯作者: Colgan, KJ